Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and bone sarcoma group.
Authors
Verweij, JaapLee, Siow Ming
Ruka, W
Buesa, J
Coleman, R
Van Hoessel, R
Seynaeve, C
Di Paola, E D
Van Glabbeke, Martine M
Tonelli, D
Judson, Ian R
Affiliation
Department of Medical Oncology, Rotterdam Cancer Institute, and University Hospital Rotterdam, Nijmegen, the Netherlands.Issue Date
2000-05